Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/1991
11/18/1991CA2042795A1 Antiviral agents
11/18/1991CA2038899A1 Method for controlled dermal penetration and topical compositions useful therefor
11/17/1991CA2017037A1 Composition for treatment of progressive myopia
11/16/1991CA2042569A1 Stabilized fgf composition
11/16/1991CA2042333A1 Spermicidal coating composition
11/16/1991CA2042250A1 Capsule-shaped tablet
11/15/1991WO1991018012A1 Cell internalizable conjugates and complexes including intracellularly cleavable moieties
11/15/1991CA2059649A1 Cell internalizable conjugates and complexes including intracellularly cleavable moieties
11/14/1991WO1991017424A1 Intracellular delivery of biologically active substances by means of self-assembling lipid complexes
11/14/1991WO1991016930A1 Composition for transdermal penetration of medicaments
11/14/1991WO1991016929A1 A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
11/14/1991WO1991016920A1 Lipid prodrugs of salicylate and nonsteroidal anti-inflammatory drugs
11/14/1991WO1991016899A1 Composition for solid pharmaceutical preparations containing vitamin d3 derivative and process for preparation thereof
11/14/1991WO1991016893A1 Pharmaceutical formulation
11/14/1991WO1991016886A1 Pharmaceutical composition containing ibuprofen and a prostaglandin
11/14/1991WO1991016885A1 Dosage form to deliver an antiparkinson agent
11/14/1991WO1991016884A1 Multi-unit pulsatile delivery system
11/14/1991WO1991016881A1 Colonic drug delivery system
11/14/1991WO1991015244A3 Stable microbubbles suspensions injectable into living organisms
11/14/1991CA2082156A1 Colonic drug delivery system
11/14/1991CA2081569A1 Composition for solid pharmaceutical preparations containing vitamin d3 derivative and process for preparation thereof
11/14/1991CA2081349A1 Pharmaceutical formulation
11/13/1991EP0456153A1 Galenical aqueous formulations containing erythropoietin and use thereof
11/13/1991EP0456106A2 Stable emulsion for pharmaceutical administration, process for its preparation and use thereof as pharmaceutical
11/13/1991EP0455753A1 Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration
11/13/1991EP0455648A1 Dosage form for administering calcium antagonist.
11/13/1991EP0455631A1 Preparation containing salicylic acid for treating desquamative skin diseases.
11/13/1991EP0414806A4 High ratio active agent:lipid complex
11/13/1991CN1056055A Percutaneously absorbable eperisone or tolperisone preparation
11/13/1991CN1056054A Encapsulation of environmentally sensitive materials
11/12/1991US5064857 Liquid bismuth containing medicinal product, process for producing it and its use
11/12/1991US5064829 Composition of a b vitamin and mannitol and a method for production
11/12/1991US5064815 Primycin-containing colloidal basic gel
11/12/1991US5064758 Method of preparing a mixture of ribonucleotides
11/12/1991US5064656 Uncoated pharmaceutical reaction tablet
11/12/1991US5064655 Liposome gel composition and method
11/12/1991US5064654 Mixed solvent mutually enhanced transdermal therapeutic system
11/12/1991US5064650 Outer shell insoluble at preselected salttconcentration but dissolves in mouth and nontoxic adhesive
11/12/1991US5064422 Twin patch applicator
11/12/1991CA2041920A1 Stable emulsion suitable for pharmaceutical administration, the production thereof and emulsion for pharmaceutical use
11/10/1991WO1991016883A1 Controlled release vehicle
11/10/1991CA2082496A1 Controlled release vehicle
11/09/1991WO1991016882A1 Direct spray-dried drug/lipid powder composition
11/09/1991CA2081474A1 Direct spray-dried drug/lipid powder composition
11/08/1991WO1991016891A1 Treatment of chronic obstructive pulmonary disease (copd) by inhalation of an imidazoline
11/08/1991CA2081768A1 Treatment of chronic obstructive pulmonary disease (copd) by inhalation of an imidazoline
11/06/1991EP0455599A1 Flavor enhancing and medicinal taste masking agent
11/06/1991EP0455598A1 Microencapsulated flavoring agents and methods for preparing same
11/06/1991EP0455561A1 New pharmaceutical compositions containing polycarbophil
11/06/1991EP0455528A1 Cosmetic or dermopharmaceutical composition containing vesicles formed of a mixture of phospholipies/glycolipids
11/06/1991EP0455503A1 Composition for treating osteoporosis and hormonal imbalance
11/06/1991EP0455475A2 Use of triclosan in the treatment of diseases of the gastrointestinal tract
11/06/1991EP0455463A1 Packaging for microdoses of powdered medicament for inhalation
11/06/1991EP0455458A2 Crosslinked pressure-sensitive adhesives tolerant of alcohol-based excipients used in transdermal delivery devices and method of preparing same
11/06/1991EP0455422A2 Method of treating or preventing baldness with compositions containing fibroblast growth factor
11/06/1991EP0455396A1 Aqueous gel compositions and their use
11/06/1991EP0455391A2 Granulated preparations and method of producing the same
11/06/1991EP0455386A1 Fat based food products
11/06/1991EP0454733A1 Osmotically dependent vesicles
11/06/1991CN1055950A Method and apparatus for inducing transformations in waxes
11/06/1991CN1055877A Process for preparing chinese-medicinal chew tablet
11/06/1991CN1055875A Spherical seed cores, spherical granules and process for production thereof
11/06/1991CN1055874A Aqueous ophthalmic solutions and method for preserving same
11/05/1991WO1991017170A1 Multimeric gelsolin fusion constructs
11/05/1991US5063249 Nonirritating teat dip and method
11/05/1991US5063220 Parenteral formulations of 1-diphenylmethyl-4-((2-(4-methylphenyl)-5-methyl-1H-imidazol-4-yl)methyl)piperazine
11/05/1991US5063203 Anticoagulants, humans
11/05/1991US5063063 Hypoadherent dressings comprising liquid pervious polymer coating of polyurethane containing siloxane residues
11/05/1991US5063061 Antiallergens
11/05/1991US5063060 Compositions and method for treating painful, inflammatory or allergic disorders
11/05/1991US5062841 Implantable, self-regulating mechanochemical insulin pump
11/05/1991US5062829 Relates to devices for administering a substance such as a drug or chemical or the like
11/05/1991US5062423 Equine aerosol drug delivery method and apparatus
11/05/1991CA2063593A1 Multimeric gelsolin fusion constructs
11/05/1991CA2041799A1 Composition for treating osteoporosis and hormonal imbalance
11/05/1991CA2041700A1 Microencapsulated flavoring agents and methods for preparing same
11/05/1991CA2040862A1 Spray granules or microgranules of pure riboflavin which contain no binder, are non-dusting and free flowing, and the preparation thereof
11/05/1991CA1291686C Non-combustible simulated cigarette device
11/04/1991WO1991016895A1 Pharmaceutical composition
11/04/1991CA2041703A1 Flavor enhancing and increasing efficacy of cough drops
11/04/1991CA2041702A1 Flavor enhancing and medicinal taste masking agent
11/03/1991WO1991017215A1 Matrix system based on thermoplastic silicone copolymer
11/03/1991CA2077745A1 Thermoplastic silicone copolymer-based matrix system
11/03/1991CA2039586A1 Crosslinked pressure-sensitive adhesives tolerant of alcohol-based excipients used in transdermal delivery devices and method of preparing same
11/03/1991CA2031864A1 Multi-unit pulsatile delivery system
11/02/1991WO1991016887A1 Biodegradable polyesters for sustained drug delivery
11/02/1991CA2081897A1 Biodegradable polyesters for sustained drug delivery
10/1991
10/31/1991WO1991016444A1 Enzymatic synthesis of soluble phosphatides from phospholipids
10/31/1991WO1991016347A1 Composition for macrophage activation
10/31/1991WO1991016085A1 Polyisobutylene adhesives for transdermal devices
10/31/1991WO1991016077A1 Improved method to administer drugs by iontophoresis
10/31/1991WO1991016072A1 Hydroxyapatite-antigen conjugates and methods for generating a poly-ig immune response
10/31/1991WO1991016068A1 Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
10/31/1991WO1991016045A2 Use of 5-ht4 receptor antagonists in the treatment of arrythmias and stroke
10/31/1991WO1991016043A1 Pharmaceutical formulations
10/31/1991WO1991016042A1 Controlled release drug formulation
10/31/1991WO1991016040A1 Liposome composition
10/31/1991WO1991016039A1 Process for the preparation of aqueous liposome suspensions containing active substances
10/31/1991WO1991016038A1 Pharmaceutical aerosol formulation of solid polypeptide microparticles and method for the preparation thereof
10/31/1991WO1991016024A1 Cationic lipids for intracellular delivery of biologically active molecules
1 ... 2840 2841 2842 2843 2844 2845 2846 2847 2848 2849 2850 2851 2852 2853 2854 2855 2856 2857 2858 2859 2860 ... 2991